CD150-mediated Akt signalling pathway in normal and malignant B cells

Aim of this article is to study upstream and downstream events in CD150-mediated Akt signaling pathway in normal human B cells, EBV-transformed lymphoblastoid (LCL) and malignant Hodgkin’s lymphoma (HL) B cell lines.

Saved in:
Bibliographic Details
Published in:Experimental Oncology
Date:2011
Main Authors: Yurchenko, M., Shlapatska, L.M., Romanets, O.L., Ganshevskiy, D., Kashuba, E., Zamoshnikova, A., Ushenin, Yu.V., Snopok, B.A., Sidorenko, S.P.
Format: Article
Language:English
Published: Інститут експериментальної патології, онкології і радіобіології ім. Р.Є. Кавецького НАН України 2011
Subjects:
Online Access:https://nasplib.isofts.kiev.ua/handle/123456789/32312
Tags: Add Tag
No Tags, Be the first to tag this record!
Journal Title:Digital Library of Periodicals of National Academy of Sciences of Ukraine
Cite this:CD150-mediated Akt signalling pathway in normal and malignant B cells / M. Yurchenko, L.M. Shlapatska, O.L. Romanets, D. Ganshevskiy, E. Kashuba, A. Zamoshnikova, Yu.V. Ushenin, B.A. Snopok, S.P. Sidorenko // Experimental Oncology. — 2011. — Т. 33, № 1. — С. 9-18. — Біліогр.: 53 назв. — англ.

Institution

Digital Library of Periodicals of National Academy of Sciences of Ukraine
id nasplib_isofts_kiev_ua-123456789-32312
record_format dspace
spelling Yurchenko, M.
Shlapatska, L.M.
Romanets, O.L.
Ganshevskiy, D.
Kashuba, E.
Zamoshnikova, A.
Ushenin, Yu.V.
Snopok, B.A.
Sidorenko, S.P.
2012-04-16T20:12:38Z
2012-04-16T20:12:38Z
2011
CD150-mediated Akt signalling pathway in normal and malignant B cells / M. Yurchenko, L.M. Shlapatska, O.L. Romanets, D. Ganshevskiy, E. Kashuba, A. Zamoshnikova, Yu.V. Ushenin, B.A. Snopok, S.P. Sidorenko // Experimental Oncology. — 2011. — Т. 33, № 1. — С. 9-18. — Біліогр.: 53 назв. — англ.
1812-9269
https://nasplib.isofts.kiev.ua/handle/123456789/32312
Aim of this article is to study upstream and downstream events in CD150-mediated Akt signaling pathway in normal human B cells, EBV-transformed lymphoblastoid (LCL) and malignant Hodgkin’s lymphoma (HL) B cell lines.
We thank Dr. E.A. Clark for valuable discussion and anti-CD40 antibodies, and Dr. K. Nichols for providing anti-SH2D1A antibodies and GST-SH2D1A construct. This work was supported by Ukrainian governmental grants 0110011001100110U006647 and 0100100107U0022002244, and by Swedish Institute in the frame of Visby program.
en
Інститут експериментальної патології, онкології і радіобіології ім. Р.Є. Кавецького НАН України
Experimental Oncology
Original contributions
CD150-mediated Akt signalling pathway in normal and malignant B cells
Article
published earlier
institution Digital Library of Periodicals of National Academy of Sciences of Ukraine
collection DSpace DC
title CD150-mediated Akt signalling pathway in normal and malignant B cells
spellingShingle CD150-mediated Akt signalling pathway in normal and malignant B cells
Yurchenko, M.
Shlapatska, L.M.
Romanets, O.L.
Ganshevskiy, D.
Kashuba, E.
Zamoshnikova, A.
Ushenin, Yu.V.
Snopok, B.A.
Sidorenko, S.P.
Original contributions
title_short CD150-mediated Akt signalling pathway in normal and malignant B cells
title_full CD150-mediated Akt signalling pathway in normal and malignant B cells
title_fullStr CD150-mediated Akt signalling pathway in normal and malignant B cells
title_full_unstemmed CD150-mediated Akt signalling pathway in normal and malignant B cells
title_sort cd150-mediated akt signalling pathway in normal and malignant b cells
author Yurchenko, M.
Shlapatska, L.M.
Romanets, O.L.
Ganshevskiy, D.
Kashuba, E.
Zamoshnikova, A.
Ushenin, Yu.V.
Snopok, B.A.
Sidorenko, S.P.
author_facet Yurchenko, M.
Shlapatska, L.M.
Romanets, O.L.
Ganshevskiy, D.
Kashuba, E.
Zamoshnikova, A.
Ushenin, Yu.V.
Snopok, B.A.
Sidorenko, S.P.
topic Original contributions
topic_facet Original contributions
publishDate 2011
language English
container_title Experimental Oncology
publisher Інститут експериментальної патології, онкології і радіобіології ім. Р.Є. Кавецького НАН України
format Article
description Aim of this article is to study upstream and downstream events in CD150-mediated Akt signaling pathway in normal human B cells, EBV-transformed lymphoblastoid (LCL) and malignant Hodgkin’s lymphoma (HL) B cell lines.
issn 1812-9269
url https://nasplib.isofts.kiev.ua/handle/123456789/32312
citation_txt CD150-mediated Akt signalling pathway in normal and malignant B cells / M. Yurchenko, L.M. Shlapatska, O.L. Romanets, D. Ganshevskiy, E. Kashuba, A. Zamoshnikova, Yu.V. Ushenin, B.A. Snopok, S.P. Sidorenko // Experimental Oncology. — 2011. — Т. 33, № 1. — С. 9-18. — Біліогр.: 53 назв. — англ.
work_keys_str_mv AT yurchenkom cd150mediatedaktsignallingpathwayinnormalandmalignantbcells
AT shlapatskalm cd150mediatedaktsignallingpathwayinnormalandmalignantbcells
AT romanetsol cd150mediatedaktsignallingpathwayinnormalandmalignantbcells
AT ganshevskiyd cd150mediatedaktsignallingpathwayinnormalandmalignantbcells
AT kashubae cd150mediatedaktsignallingpathwayinnormalandmalignantbcells
AT zamoshnikovaa cd150mediatedaktsignallingpathwayinnormalandmalignantbcells
AT usheninyuv cd150mediatedaktsignallingpathwayinnormalandmalignantbcells
AT snopokba cd150mediatedaktsignallingpathwayinnormalandmalignantbcells
AT sidorenkosp cd150mediatedaktsignallingpathwayinnormalandmalignantbcells
first_indexed 2025-12-02T00:01:56Z
last_indexed 2025-12-02T00:01:56Z
_version_ 1850861211543928832